These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12756410)

  • 1. Hyperhomocysteinemia but not MTHFR genotype is associated with young-onset essential hypertension.
    Garfunkel VA; Porto PI; Garcia SI; Dieuzeide G; Kirszner T; Plotquin Y; Spataro RJ; Gonzalez C; Pirola CJ
    J Hum Hypertens; 2003 May; 17(5):361-4. PubMed ID: 12756410
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic basis of hyperhomocysteinemia.
    Medina MA; Amores-Sánchez MI
    Mol Genet Metab; 2000 Nov; 71(3):478-80. PubMed ID: 11073715
    [No Abstract]   [Full Text] [Related]  

  • 3. Intermediate and severe hyperhomocysteinemia with thrombosis: a study of genetic determinants.
    Gaustadnes M; Rüdiger N; Rasmussen K; Ingerslev J
    Thromb Haemost; 2000 Apr; 83(4):554-8. PubMed ID: 10780316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of polymorphic variants of the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene in the pathogenesis of cardiovascular diseases].
    Spiridonova MG; Stepanov VA; Puzyrev VP
    Klin Med (Mosk); 2001; 79(2):10-6. PubMed ID: 11419077
    [No Abstract]   [Full Text] [Related]  

  • 5. Heterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinemia associated with deep vein thrombosis.
    Pathare A; al Kindi S; al Belushi T; Bayoumi R; Dennison D; Murlitharan S
    Haematologia (Budap); 2002; 32(4):551-6. PubMed ID: 12803132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation of the methylenetetrahydrofolate reductase and cystathionine beta-synthase genes in Korean patients with coronary artery disease and a new polymorphism in intron 7.
    Hong SH; Song J; Kim JQ
    Mol Cell Probes; 2001 Apr; 15(2):119-23. PubMed ID: 11292330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperhomocysteinemia and C677T mutation of methylenetetrahydrofolate reductase].
    Grasa Ullrich JM; Torres Gómez M; Sánchez Marín B; Calvo Martín MT; García Erce JA; Giralt Raichs M
    An Med Interna; 2002 May; 19(5):269. PubMed ID: 12108010
    [No Abstract]   [Full Text] [Related]  

  • 8. Homocysteine and ischaemic heart disease.
    Law MR; Wald NJ
    Haematologica; 1999 Jun; 84 Suppl EHA-4():57-60. PubMed ID: 10907469
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutations in the genes regulating methylene tetrahydrofolate reductase (MTHFR C-->T677) and cystathione beta-synthase (CBS G-->A919, CBS T-->c833) are not associated with myocardial infarction in African Americans.
    Dilley A; Hooper WC; El-Jamil M; Renshaw M; Wenger NK; Evatt BL
    Thromb Res; 2001 Jul; 103(2):109-15. PubMed ID: 11457468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetics of homocysteine metabolism.
    Födinger M; Buchmayer H; Sunder-Plassmann G
    Miner Electrolyte Metab; 1999; 25(4-6):269-78. PubMed ID: 10681651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinemia, MTHFR, and risk of vascular disease.
    Blom HJ; Verhoef DP
    Circulation; 2000 Apr; 101(16):E171; author reply E173. PubMed ID: 10779473
    [No Abstract]   [Full Text] [Related]  

  • 12. Two mutations in the MTHFR gene associated with mild hyperhomocysteinaemia.
    Tikly M; Zannettou N; Traub B
    S Afr Med J; 2003 Mar; 93(3):161-2. PubMed ID: 12768933
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to "genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A".
    Isotalo PA; Donnelly JG
    Am J Med Genet; 2002 Jun; 110(2):191-2. PubMed ID: 12116261
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperhomocysteinemia: another independent vascular risk factor.
    Deleu D
    Saudi Med J; 2000 Aug; 21(8):787-8. PubMed ID: 11423902
    [No Abstract]   [Full Text] [Related]  

  • 15. Statistical approaches for evaluation of genetic risk factor of peripheral arterial occlusive disease.
    Svatos J; Orendác M; Musková B; Hyánek J; Kozich V; Zvárová J
    Stud Health Technol Inform; 1999; 68():419-22. PubMed ID: 10724918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombosis-associated gene variants in sickle cell anemia.
    Romana M; Muralitharan S; Ramasawmy R; Nagel RL; Krishnamoorthy R
    Thromb Haemost; 2002 Feb; 87(2):356-8. PubMed ID: 11858507
    [No Abstract]   [Full Text] [Related]  

  • 17. Possible interaction of genotypes at cystathionine beta-synthase and methylenetetrahydrofolate reductase (MTHFR) in neural tube defects. NTD Collaborative Group.
    Speer MC; Nye J; McLone D; Worley G; Melvin EC; Viles KD; Franklin A; Drake C; Mackey J; George TM
    Clin Genet; 1999 Aug; 56(2):142-4. PubMed ID: 10517251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylenetetrahydrofolate reductase gene and coronary artery disease.
    Mager A
    Circulation; 2000 Apr; 101(16):E172-3. PubMed ID: 10779474
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperhomocysteinemia, MTHFR 677C-->T polymorphism, and stroke.
    Kelly PJ; Barron M; Furie KL
    Stroke; 2002 Jun; 33(6):1452-3; author reply 1452-3. PubMed ID: 12052968
    [No Abstract]   [Full Text] [Related]  

  • 20. The prevalence of MTHFR 677C-->T missense mutation, total plasma homocysteine levels and associated risk factors in Malay subjects.
    Ling KH; Rosli R; Duraisamy G; Nasir MT
    Med J Malaysia; 2003 Jun; 58(2):243-54. PubMed ID: 14569745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.